Hopstem: Funding, Investors & Team (Oct 2026)
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
Hopstem has raised $29.6M across 1 funding round on record, the most recent a Series C of $29.6M announced in Aug 2026.
That round is above the $15M median round size for China companies tracked on FundedIQ over the last two years.
Hopstem Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Hopstem Funding Rounds
Hopstem Investors
10 investors are recorded in total; the 5 named above are those the record identifies.
Hopstem Founders and Leadership Team
Contact details for the Hopstem team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Hopstem Funding in Context
Hopstem's latest round of $29.6M is above the median round in China. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hopstem in Biotechnology and Hangzhou
Companies Similar to Hopstem
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune…
Novellusdx develops tumor specific driver mutations.
Sudu Technology is a high-tech enterprise specializing in the research and development of general-purpose…
Haoxinqing is an online medical service platform focusing on the fields of mental psychology and chronic…
Leadsynbio is a leading supplier of APIs, Human & Animal Nutrition ingredients. Innovative synthetic biology…
Zhongke lon engages in manufacturing high-end medical devices such as proton therapy equipment.
MaxSense Technology is an autonomous driving and industrial operation optimization developer company.
Sleptay is an innovative biopharmaceutical company, developing next-generation therapies for central nervous…
Xunjie Guangyuan operates engages in the research and development of near-infrared spectroscopy analysis…
Juxie Intelligent is an intelligent technology company that specializes in the development and production of…
Xige Estate operates a wine estate that has more than 30,000 acres of its own vineyards.
Tujian Technology heps in the development of multimodal flexible tactile sensors, application software…
Hopstem Funding FAQs
What does Hopstem do?
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering.
How much funding has Hopstem raised?
Hopstem has raised $29.6M across 1 round on record. The most recent is a Series C of $29.6M announced in Aug 2026.
When did Hopstem last raise funding?
Hopstem's most recent funding round on record is a Series C of $29.6M, announced in Aug 2026.
Who has invested in Hopstem?
Investors on record for Hopstem include Lilly Asia Ventures, BioVenture, Hillhouse Ventures, Longmen Capital, Haibang Capital. FundedIQ records 10 investors in total.
Who is the CEO of Hopstem?
Jing Fan is listed as CEO at Hopstem.
Where is Hopstem headquartered?
Hopstem is based in Hangzhou, China.
How many employees does Hopstem have?
Hopstem is in the 51-100 employee band.
When was Hopstem founded?
Hopstem was founded in 2017.
About FundedIQ's Hopstem Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hopstem is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.